OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.190
-0.090 (-7.03%)
Aug 1, 2025, 4:00 PM - Market closed
OPKO Health Stock Forecast
Stock Price Forecast
The 3 analysts that cover OPKO Health stock have a consensus rating of "Buy" and an average price target of $2.75, which forecasts a 131.09% increase in the stock price over the next year. The lowest target is $2.25 and the highest is $3.00.
Price Target: $2.75 (+131.09%)
Analyst Consensus: Buy
* Price targets were last updated on May 1, 2025.
Analyst Ratings
The average analyst rating for OPKO Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +89.08% | May 1, 2025 |
| JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Apr 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +152.10% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +152.10% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +152.10% | Mar 12, 2025 |
Financial Forecast
Revenue This Year
656.02M
from 713.14M
Decreased by -8.01%
Revenue Next Year
701.84M
from 656.02M
Increased by 6.98%
EPS This Year
-0.35
from -0.08
EPS Next Year
-0.21
from -0.35
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 714.7M | 807.9M | 878.3M | ||
| Avg | 656.0M | 701.8M | 817.5M | ||
| Low | 604.0M | 601.7M | 766.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.2% | 23.1% | 25.1% | ||
| Avg | -8.0% | 7.0% | 16.5% | ||
| Low | -15.3% | -8.3% | 9.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.23 | -0.11 | -0.08 |
| Avg | -0.35 | -0.21 | -0.09 |
| Low | -0.49 | -0.35 | -0.10 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.